May Social Media Round-Up—Q1 Earning Results, Bladder Cancer Awareness Month, and More

The month of May flew by with more exciting updates and announcements from Pfizer across social media. Time flies when you’re making breakthroughs.

On our corporate channels, we launched our new “The Mindfulness of Medicine Development” series, highlighted how Pfizer researchers are paving the way for new cancer innovations, and showcased how Pfizer colleagues are supporting people with bladder cancer, leukemia, and more.

Meanwhile, CEO Albert Bourla proudly shared Pfizer’s Q1 2025 earning results and honored mothers everywhere for Mother’s Day. The rest of our leadership team recognized luminaries and rising stars at Pfizer, furthered the conversation on AI transformation at the BioPhorum IT Digital and Data F2F event, and shined a light on Mental Health Awareness month.

See what else we got up to this month and follow our channels for more.

Executive Leadership

• CEO Albert Bourla highlights Pfizer’s Q1 2025 earning results
• Chief U.S. Commercial Officer Aamir Malik congratulates Pfizer colleagues who have been recognized as 2025 Luminaries and Rising Stars by the Healthcare Businesswomen’s Association
• Chief Digital and Technology Officer Lidia Fonseca speaks at the BioPhorum IT Digital and Data F2F event about AI transformation
• CEO Albert Bourla honors the incredible mothers in our lives on Mother’s Day
• Chief People Experience Officer Payal Sahni Becher raises awareness of mental health matters for Mental Health Awareness month
• Chief U.S. Commercial Officer Aamir Malik joins Pfizer's second Middle Eastern North African Resource Alliance (MENARA) Summit

Pfizer on LinkedIn

• Pfizer colleagues show support for the bladder cancer community by joining the Walk to End Bladder Cancer
• Pfizer is committed to breaking the silence on the importance of bowel health for World IBD Day
• Pfizer colleague, Alex, raises awareness in the Asian American community about the critical need for diverse bone marrow donors for people diagnosed with leukemia
• Pfizer will be sharing new data for our approved therapies and investigational next-generation treatment pipeline at ESMO Breast Cancer 2025
• Pfizer’s new “The Mindfulness of Medicine Development” series invites you to get to know our colleagues and their roles in developing potential new medicines, starting with chemical biologist, Jaimeen

Pfizer on Instagram

• Pfizer’s latest episode of “Front Porch Conversations” shares the importance of early detection in cancer
• Pfizer shares the importance of advocating for your own health with the patient story of Brian who was determined to overcome his bladder cancer diagnosis
• Pfizer shares our gratitude for the people who move progress in medicine forward for Clinical Trials Day
• The BMS-Pfizer Alliance highlight Stroke Awareness Month with the No Time to Wait campaign
• Pfizer’s “The Mindfulness of Medicine Development” shares Pfizer colleague John’s journey and how his team helps improve outcomes for people with cardiometabolic diseases

Pfizer on X

• TIME highlights how Pfizer’s early-stage researchers are paving the way for new cancer innovations
• Pfizer will share overall survival data in metastatic hormone-sensitive prostate cancer at ASCO 2025
• Pfizer’s “The Mindfulness of Medicine Development” sits down with Pfizer colleague, Brett, whose team brings the patient voice into the development of new medical breakthroughs